Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 80 for “"Neuroprotective agents"”.
-
Antihistamines as neuroprotective agents
… neurotoxic effects in rat brain homogenates, the neuroprotective properties of the histamine antagonists were examined and compared to aspirin. Superoxide anion levels and malondialdehyde concentrations were assessed using the nitrobluetetrazolium and lipid peroxidation assays. Clobenpropit and …
-
Synthesis of Fluoroflavones as Potential Neuroprotective Agents
… natural products that are known to have neuroprotective effects against many diseases caused by the formation of reactive species. Flavonoids are subgroup of flavones and they are believed to function as antioxidants. Specifically, they target free radicals and eliminate its harmful …
-
Curcumin/Melatonin Hybrids as Neuroprotective Agents for Alzheimer's disease
… mainly symptomatic relief and there are no agents available to delay or cure this disease. Multiple factors such as amyloid-β aggregates, dyshomeostasis of biometals, oxidative stress, and neuroinflammation have been implicated in the development of AD. Even though significant advances have …
-
Discovery of potential anticancer and neuroprotective agents from North Queensland plants
… cytotoxic compounds with potential as anticancer agents. The second screen aimed to find compounds with therapeutic potential in schizophrenia or neurological disorders that involve neuroinflammation and neurodegeneration, such as Huntington’s Disease and AIDS-related dementia. Various imbalances …
-
In vitro characterisation of neuroprotective agents and cell sources for cell replacement therapies for Parkinson's disease
… symptoms and do not provide permanent cure. Neuroprotective therapies could be an option for early disease stages. In order to investigate possible neuroprotective agents, it is necessary to have an adequate cell culture model. For already advanced disease stages, neurorestorative approaches …
-
Histone deacetylase inhibitors as novel neuroprotective agents in in vitro and in vivo models of Parkinson’s disease
Histone deacetylases (HDAC) shift the balance towards chromatin condensation and silence gene expression. Aberrant recruitment of HDACs to alter transcription suggests the use of HDAC inhibitors (HDAC-Is) as potential therapeutic candidates for neurodegenerative disorders such as Parkinson’s …
-
Progress Toward the Synthesis of 3-Methoxyflavones as Potential Antioxidants, Neuroprotective Agents, and Trifluoromethylated 19F NMR Probes
The total synthesis of polyhydroxylated flavones have proven to be challenging, due to the presence of more than one hydroxyl group. Direct cyclization was not successful in any of the attempts. However, by using a silyl protecting group, the cyclization was feasible. Other reactions like the …
-
Study of Combinatorial Cell Therapy and Neuroprotective Agents for the Treatment of Spinal Cord Injury in Experimental Models
[ES] La lesión medular (LM) es un trastorno neurológico devastador y debilitante que se caracteriza por un grado variable de disfunción motora, sensorial y/o autonómica permanente. El trasplante de células madre neurales (NSC) ofrece una herramienta terapéutica prometedora para el tratamiento de la …
-
Neuroprotective Drug Delivery to the Injured Spinal Cord with Hyaluronan and Methylcellulose
… which there is no effective clinical treatment. Neuroprotective molecules that minimize tissue loss have shown promising results; however systemic delivery may limit in vivo benefits due to short systemic half-life and minimal passage across the blood-spinal cord barrier. To overcome these …
-
Management of autonomic dysfunction following spinal cord injury : current practices, barriers, and potential treatment options
… spinal cord damage and preserve key pathways. Neuroprotective agents with anti-inflammatory properties have been explored for motor recovery in rodents following SCI, however, their potential impact on cardiovascular function remains relatively underexplored. This study evaluated four …
-
A combinatorial approach to the search for anticonvulsant agents from gou teng and tian ma
… thus the discovery of new antiepileptic agents is urgently needed. Gou Teng and Tian Ma are two famous Traditional Chinese Medicines (TCMs) widely used in the treatment of epilepsy. Some oxindole alkaloids of Gou Teng have been shown to be antagonists of NMDA receptor, possibly …
-
Efeitos de N-acetilcisteína em um modelo de Doença de Parkinson em larvas de peixe-zebra
… pharmacological strategy is to introduce neuroprotective agents at an earlier stage in order to prevent further neuronal death. N-acetylcysteine (NAC) is an antioxidant, anti-inflammatory and glutamatergic modulator that has shown various therapeutic benefits in brain disorders. In this …
-
Μελέτη της επίδρασης της αναισθησίας σε νευροεκφυλιστικές παθήσεις του εγκεφάλου: πειραματική μελέτη
… (pMCAO) alone or in combination with a well-knownneuroprotective agent, simvastatin. For this study C57BL/6J mice (n=40) wereselected and were subjected to pMCAO using coagulation. For the anesthesiaketamine/xylazine or isoflurane were used in the absence or presence ofsimvastatin. A comparative …
-
In vivo εφαρμογή νευροπροστατευτικών παραγόντων σε ισχιακό νεύρο επίμυος, μετά από πρόκληση ισχαιμίας / επαναιμάτωσης και εκτίμηση του αποτελέσματος με ιστοχημικές μεθόδους
… The reversion of abnormalities by the applied neuroprotective agents might prove to be a clinically important finding in view of the implication of vascular supply derangement in various neuropathies in humans.
-
Fluorescent polycyclic ligands : strategies towards the synthesis and evaluation of fluorescently labelled receptor and enzyme ligands
… and Parkinson's disease, and the development of neuroprotective agents have received significant research attention in recent years. Development of novel imaging techniques to study the biological mechanisms involved in the progression of these disorders have become an area of research interest. …
-
Diffusion Weighted Magnetic Resonance Imaging (DW-MRI) of Early Stroke in Humans: A Comparison of Two Methods
… of diffusion characteristics (e.g. evaluation of neuroprotective agents and thrombolytic therapies).
-
Neuroepigenetics of preterm white matter injury
… matter integrity 2. To investigate the effect of neuroprotective treatments and deleterious clinical states on white matter integrity in preterm infants 3. To assess the best DTI method of quantifying white matter integrity in a neonatal population 4. To investigate the effect of preterm birth on …
-
Improving Blood Brain Barrier Permeation of Small Molecules Exhibiting Chemotherapeutic and Neuroprotective Effects
… molecules that possess chemotherapeutic and neuroprotective properties. These molecules also represent various strategies for improving blood brain barrier penetration. Derivatives of the microtubule stabilizing agent paclitaxel were investigated in which chemical modification was employed to …
-
Effect of Fucoxanthin on Mitochondrial Function During Excitotoxicity
… activation of cell death pathways. Investigating neuroprotective agents that mitigate mitochondrial dysfunction is crucial for developing therapeutic strategies. Fucoxanthin, a marine carotenoid with potent antioxidant properties, has demonstrated neuroprotective potential in in vitro and in vivo …
-
The Effects of Ethynodiol Diacetate on Epinephrine-Treated Glial-Derived Cells
Neuroprotective agents, including specific hormones, may play a role in preventing cellular damage following an ischemic event or brain injury. Astrocytes are specialized glial cells within the central nervous system that play roles in synapse development, blood flow regulation, extracellular …
Page 1 of 4